Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF α pour rhumatisme inflammatoire chronique

Hydroxychloroquine is an agent used as a treatment but also considered as a prophylaxis for SARS-CoV-2 infection. We report the case of a patient who developed COVID-19 while on hydroxychloroquine for mixed connectivitis associated with spondyloarthritis. Although more work is needed before any conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Malek, Saadia Ait, Bouchti, Imane El
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608760/
https://www.ncbi.nlm.nih.gov/pubmed/33193949
http://dx.doi.org/10.11604/pamj.supp.2020.35.134.25011
_version_ 1783604893860233216
author Malek, Saadia Ait
Bouchti, Imane El
author_facet Malek, Saadia Ait
Bouchti, Imane El
author_sort Malek, Saadia Ait
collection PubMed
description Hydroxychloroquine is an agent used as a treatment but also considered as a prophylaxis for SARS-CoV-2 infection. We report the case of a patient who developed COVID-19 while on hydroxychloroquine for mixed connectivitis associated with spondyloarthritis. Although more work is needed before any conclusions can be drawn, this raises questions about the protective role of this drug against infection. Are they really protected against COVID-19 or will they develop pauci-symptomatic forms?
format Online
Article
Text
id pubmed-7608760
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-76087602020-11-13 Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF α pour rhumatisme inflammatoire chronique Malek, Saadia Ait Bouchti, Imane El Pan Afr Med J Case Report Hydroxychloroquine is an agent used as a treatment but also considered as a prophylaxis for SARS-CoV-2 infection. We report the case of a patient who developed COVID-19 while on hydroxychloroquine for mixed connectivitis associated with spondyloarthritis. Although more work is needed before any conclusions can be drawn, this raises questions about the protective role of this drug against infection. Are they really protected against COVID-19 or will they develop pauci-symptomatic forms? The African Field Epidemiology Network 2020-08-05 /pmc/articles/PMC7608760/ /pubmed/33193949 http://dx.doi.org/10.11604/pamj.supp.2020.35.134.25011 Text en Copyright: Saadia Ait Malek et al. https://creativecommons.org/licenses/by/4.0 The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Malek, Saadia Ait
Bouchti, Imane El
Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF α pour rhumatisme inflammatoire chronique
title Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF α pour rhumatisme inflammatoire chronique
title_full Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF α pour rhumatisme inflammatoire chronique
title_fullStr Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF α pour rhumatisme inflammatoire chronique
title_full_unstemmed Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF α pour rhumatisme inflammatoire chronique
title_short Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF α pour rhumatisme inflammatoire chronique
title_sort une infection par le sars-cov-2 chez un patient sous hydroxychloroquine et anti tnf α pour rhumatisme inflammatoire chronique
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608760/
https://www.ncbi.nlm.nih.gov/pubmed/33193949
http://dx.doi.org/10.11604/pamj.supp.2020.35.134.25011
work_keys_str_mv AT maleksaadiaait uneinfectionparlesarscov2chezunpatientsoushydroxychloroquineetantitnfapourrhumatismeinflammatoirechronique
AT bouchtiimaneel uneinfectionparlesarscov2chezunpatientsoushydroxychloroquineetantitnfapourrhumatismeinflammatoirechronique

Ejemplares similares